Aspen Neuroscience Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
120
- Stock Symbol
-
ASPE
- Share Price
-
$12.62
- (As of Friday Closing)
Aspen Neuroscience General Information
Description
Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.
Contact Information
Website
www.aspenneuroscience.comCorporate Office
- 10835 Road to the Cure
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 10835 Road to the Cure
- Suite 100
- San Diego, CA 92121
- United States
Aspen Neuroscience Timeline
Aspen Neuroscience Stock Performance
As of 13-Nov-2026, Aspen Neuroscience’s stock price is $12.62. Its current market cap is $366M with 29.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.62 | $13.61 | $11.20 - $14.90 | $366M | 29.1M | 405K | -$4.89 |
Aspen Neuroscience Financials Summary
As of 30-Jun-2026, Aspen Neuroscience has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| EBITDA | (65,314) | (59,891) | (49,441) |
| Net Income | (66,843) | (62,056) | (48,557) |
| Total Assets | 110,275 | 143,663 | 90,211 |
| Total Debt | 9,771 | 11,201 | 13,829 |
Aspen Neuroscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aspen Neuroscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Aspen Neuroscience Comparisons
Industry
Financing
Details
Aspen Neuroscience Competitors (55)
One of Aspen Neuroscience’s 55 competitors is Capricor Therapeutics, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Minoryx | Venture Capital-Backed | Barcelona, Spain | ||||
| BlueRock Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Prevail Therapeutics | Formerly VC-backed | New York, NY | ||||
| Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA |
Aspen Neuroscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aspen Neuroscience Patents
Aspen Neuroscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260105763-A1 | Automated cell manufacturing methods and systems | Pending | 25-Sep-2024 | ||
| WO-2026072731-A1 | Automated cell manufacturing methods and systems | Pending | 25-Sep-2024 | ||
| US-20250382572-A1 | Automated methods for differentiating dopaminergic neurons from stem cells | Pending | 13-Jun-2024 | ||
| WO-2025260067-A2 | Automated methods for differentiating dopaminergic neurons from stem cells | Pending | 13-Jun-2024 | ||
| WO-2025260067-A3 | Automated methods for differentiating dopaminergic neurons from stem cells | Pending | 13-Jun-2024 | C12N5/0623 |
Aspen Neuroscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aspen Neuroscience FAQs
-
When was Aspen Neuroscience founded?
Aspen Neuroscience was founded in 2018.
-
Where is Aspen Neuroscience headquartered?
Aspen Neuroscience is headquartered in San Diego, CA.
-
What is the size of Aspen Neuroscience?
Aspen Neuroscience has 120 total employees.
-
What industry is Aspen Neuroscience in?
Aspen Neuroscience’s primary industry is Drug Discovery.
-
Is Aspen Neuroscience a private or public company?
Aspen Neuroscience is a Public company.
-
What is Aspen Neuroscience’s stock symbol?
The ticker symbol for Aspen Neuroscience is ASPE.
-
What is the current stock price of Aspen Neuroscience?
As of 13-Nov-2026 the stock price of Aspen Neuroscience is $12.62.
-
What is the current market cap of Aspen Neuroscience?
The current market capitalization of Aspen Neuroscience is $366M.
-
Who are Aspen Neuroscience’s competitors?
Capricor Therapeutics, Minoryx, BlueRock Therapeutics, Prevail Therapeutics, and Aro Biotherapeutics are some of the 55 competitors of Aspen Neuroscience.
-
What is Aspen Neuroscience’s annual earnings per share (EPS)?
Aspen Neuroscience’s EPS for 12 months was -$4.89.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
